Papillary thyroid cancer epidemiology and demographics

Revision as of 20:01, 4 November 2015 by Ammu Susheela (talk | contribs)
Jump to navigation Jump to search

Papillary thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Papillary thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Papillary thyroid cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Papillary thyroid cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Papillary thyroid cancer epidemiology and demographics

CDC on Papillary thyroid cancer epidemiology and demographics

Papillary thyroid cancer epidemiology and demographics in the news

Blogs on Papillary thyroid cancer epidemiology and demographics

Directions to Hospitals Treating Papillary thyroid cancer

Risk calculators and risk factors for Papillary thyroid cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Epidemiology and Demographics

Prevalence

Incidence

  • There are 45,000 cases in the United States every year and this type of carcinoma has the fastest increasing incidence of any malignancy in the thyroid.

Case Fatality Rate

Age

  • Papillary thyroid cancer (as is the case with follicular thyroid cancer) typically occurs in the middle-aged, with a peak incidence in the 3rd and 4th decades.
  • It occurs more frequently in women and presents in the 20–55 year age group

Gender

  • It is more common in women with a female:male ratio of 1:1.6 - 3:1

Race

Developed Countries

Developing Countries

References